COM:CARISMATX
Carisma Therapeutics
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
carismatx.comcrunchbase
carma-therapeuticslinkedin
carisma-therapeuticsfounding date
Jan 01, 2016ipo date
Feb 06, 2014
Carisma Therapeutics, Inc., a biopharmaceutical company, develops chimeric antigen receptors (CAR) macrophages for the treatment of solid tumors. Its solutions are used to play a crucial role in the innate and adaptive immune response, and technology leverages advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cellular therapy for the treatment ...Show More